Shamburg News · 8-K filed Nov 12, 2026, 6:15 PM EST
ImmuCell Reports Unaudited Q3 2026 Net Income of $953,000, Product Sales Up 46.0%
ICCC · IMMUCELL CORP /DE/
- Earnings
- Financing
- Materiality: high
ImmuCell Corporation reported unaudited financial results for the quarter ended September 30, 2026, in a press release furnished under Item 2.02. Product sales rose 46.0% to approximately $8.0 million, and net income was $953,000, or $0.10 per diluted share. The company also said it terminated its At-The-Market offering and expects to sign a new $3 million line of credit with its bank in the fourth quarter of 2026.
Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001437749-26-036629.
Written from the filing by Shamburg Markets. Figures are as reported by the company.